ArticleFrontiers in neurology2022

Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases.

Georges Saab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.